{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:53:18Z","timestamp":1782978798422,"version":"3.54.5"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.diabres.2023.110644","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:57:58Z","timestamp":1680062278000},"page":"110644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Glycaemic control in people with diabetes following acute myocardial infarction"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8906-4964","authenticated-orcid":false,"given":"Harriet","family":"Esdaile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Mayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110644_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","article-title":"A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction","volume":"217","author":"Bauters","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.11.003","article-title":"Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction","volume":"47","author":"Schmitt","year":"2021","journal-title":"Diabetes Metab"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/dom.12827","article-title":"Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era","volume":"19","author":"Gholap","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jech-2016-207402","article-title":"Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study","volume":"71","author":"Alabas","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.diabres.2023.110644_b0025","doi-asserted-by":"crossref","unstructured":"Ritsinger V, Lagerqvist B, Lundman P, Hagstr\u00f6m E, Norhammar A. Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry. Diabetes and Vascular Disease Research. 2020;17(6):1479164120973676.","DOI":"10.1177\/1479164120973676"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ejhf.797","article-title":"A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database","volume":"19","author":"Tajik","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","volume":"6","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ehjcvp\/pvv023","article-title":"Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality?","volume":"1","author":"Singh","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"9206","key":"10.1016\/j.diabres.2023.110644_b0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/dc18-2047","article-title":"Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome","volume":"42","author":"Gerbaud","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0055","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","article-title":"MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart","volume":"37","author":"Costantino","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.carpath.2008.09.008","article-title":"The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control","volume":"18","author":"Marfella","year":"2009","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1210\/jc.2011-2037","article-title":"Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction","volume":"97","author":"Marfella","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.diabres.2023.110644_b0070","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.01.041","article-title":"Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients","volume":"53","author":"Marfella","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2023.110644_b0075","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/hrt.2010.197673","article-title":"Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction","volume":"96","author":"Claessen","year":"2010","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/hrt.2003.021014","article-title":"Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention","volume":"90","author":"Morgan","year":"2004","journal-title":"Heart"},{"issue":"17","key":"10.1016\/j.diabres.2023.110644_b0085","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1177\/2047487319901063","article-title":"Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry","volume":"27","author":"Ritsinger","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-126-4-199702150-00006","article-title":"Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction","volume":"126","author":"Aronson","year":"1997","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-022-01460-5","article-title":"Diabetes and restenosis","volume":"21","author":"Wilson","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1479164115592252","article-title":"Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction","volume":"12","author":"De Luca","year":"2015","journal-title":"Diab Vasc Dis Res"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2007.10.035","article-title":"Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials","volume":"51","author":"Kirtane","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era","volume":"154","author":"Iijima","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2023.110644_b0115","doi-asserted-by":"crossref","unstructured":"Billinger M, R\u00e4ber L, Hitz S, Stefanini GG, Pilgrim T, Stettler C, et al. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J. 2012;163(5):876-86.e2.","DOI":"10.1016\/j.ahj.2012.02.014"},{"key":"10.1016\/j.diabres.2023.110644_b0120","unstructured":"National Institute for Health and Care Excellence (2020). Acute Coronary Syndromes (NICE guideline NG185). https:\/\/www.nice.org.uk\/guidance\/ng185\/resources\/acute-coronary-syndromes-pdf-66142023361477 (accessed 20th August 2022)."},{"issue":"25","key":"10.1016\/j.diabres.2023.110644_b0125","first-page":"e344","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Non\u2013ST-Elevation Acute Coronary Syndromes","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110644_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12933-022-01506-8","article-title":"Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry","volume":"21","author":"Paolisso","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","article-title":"SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart","volume":"4","author":"Lim","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.29.04.06.dc05-1894","article-title":"The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction","volume":"29","author":"Cheung","year":"2006","journal-title":"Diabetes Care"},{"issue":"20","key":"10.1016\/j.diabres.2023.110644_b0165","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jamainternmed.2013.10074","article-title":"Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome: results of the Randomized BIOMarker Study to Identify the Acute Risk of a Coronary Syndrome\u20132 (BIOMArCS-2) Glucose Trial","volume":"173","author":"de Mulder","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0170","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1210\/jc.2012-1364","article-title":"Peri-Procedural Tight Glycemic Control during Early Percutaneous Coronary Intervention Is Associated with a Lower Rate of In-Stent Restenosis in Patients with Acute ST-Elevation Myocardial Infarction","volume":"97","author":"Marfella","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0175","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.ijcard.2013.06.053","article-title":"Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage","volume":"168","author":"Marfella","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/diab.36.7.808","article-title":"Progression of incipient diabetic retinopathy during good glycemic control","volume":"36","author":"Engerman","year":"1987","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1073\/pnas.87.1.404","article-title":"Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory","volume":"87","author":"Roy","year":"1990","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.diabres.2023.110644_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094589","article-title":"Epigenetic Modifications and Non-Coding RNA in diabetes-mellitus-induced coronary artery disease: pathophysiological link and new therapeutic frontiers","volume":"23","author":"Prandi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0195","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/dom.13002","article-title":"Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction","volume":"19","author":"Reinstadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"9131","key":"10.1016\/j.diabres.2023.110644_b0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.diabres.2023.110644_b0205","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2023.110644_b0215","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2023.110644_b0220","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"ADVANCE Collaborative Group.Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.diabres.2023.110644_b0225","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1806802","article-title":"Intensive Glucose Control in Patients with Type 2 Diabetes \u2014 15-Year Follow-up","volume":"380","author":"Reaven","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.diabres.2023.110644_b0230","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc15-2283","article-title":"Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"Cosentino","year":"2019","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.diabres.2023.110644_b0245","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12933-022-01637-y","article-title":"Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus","volume":"21","author":"Montone","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0255","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.mayocp.2020.08.047","article-title":"Microvascular Disease and Risk of Cardiovascular Events and Death From Intensive Treatment in Type 2 Diabetes: The ACCORDION Study","volume":"96","author":"Kloecker","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diabres.2023.110644_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901815","article-title":"Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications","volume":"13","author":"Marfella","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.diabres.2023.110644_b0265","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/diabetes.53.9.2383","article-title":"Expression of Angiogenic Factors During Acute Coronary Syndromes in Human Type 2 Diabetes","volume":"53","author":"Marfella","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0270","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-016-0373-x","article-title":"Flow cytometric analysis of platelets type 2 diabetes mellitus reveals \u2018angry\u2019 platelets","volume":"15","author":"Soma","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110644_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/781857","article-title":"Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis","volume":"2014","author":"Ghoshal","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0280","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0609.1998.tb01095.x","article-title":"Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus","volume":"61","author":"Watala","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.diabres.2023.110644_b0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prostaglandins.2015.05.002","article-title":"Platelets and diabetes mellitus","volume":"120","author":"Santilli","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0295","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2014.01.006","article-title":"High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications","volume":"28","author":"Kim","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk","volume":"16","author":"Kearney","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1479164110383723","article-title":"Coagulation and fibrinolysis in diabetes","volume":"7","author":"Alzahrani","year":"2010","journal-title":"Diab Vasc Dis Res"},{"issue":"22","key":"10.1016\/j.diabres.2023.110644_b0310","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","article-title":"Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation","volume":"97","author":"Du","year":"2000","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0315","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood-2013-04-494641","article-title":"Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity","volume":"122","author":"Ajjan","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0320","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2337\/dc18-0050","article-title":"Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes","volume":"41","author":"Chow","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0325","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2337\/db22-0246","article-title":"Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 diabetes and in people without diabetes","volume":"71","author":"Verhulst","year":"2022","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0330","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2337\/db14-1729","article-title":"Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans","volume":"64","author":"Joy","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0335","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/joa3.12708","article-title":"Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: a systematic review and meta-analysis","volume":"38","author":"Trongtorsak","year":"2022","journal-title":"J Arrhythm"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0340","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1","article-title":"Altered ventricular repolarization during hypoglycaemia in patients with diabetes","volume":"14","author":"Marques","year":"1997","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0345","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2796.1999.00528.x","article-title":"Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus","volume":"246","author":"Landstedt-Hallin","year":"1999","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0350","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2337\/db16-1310","article-title":"Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes","volume":"66","author":"Chow","year":"2017","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0355","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2007.04.118","article-title":"Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice","volume":"358","author":"Mita","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0360","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40618-014-0086-5","article-title":"Oscillating high glucose enhances oxidative stress and apoptosis in human coronary artery endothelial cells","volume":"37","author":"Liu","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12933-016-0427-0","article-title":"Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo","volume":"15","author":"Wu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0370","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00011-013-0623-2","article-title":"Periodic vs constant high glucose in inducing pro-inflammatory cytokine expression in human coronary artery endothelial cells","volume":"62","author":"Liu","year":"2013","journal-title":"Inflamm Res"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0375","doi-asserted-by":"crossref","first-page":"E924","DOI":"10.1152\/ajpendo.2001.281.5.E924","article-title":"Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture","volume":"281","author":"Risso","year":"2001","journal-title":"Am J Physiol-Endocrinol Metabolism"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12933-015-0275-3","article-title":"Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes","volume":"14","author":"Okada","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110644_b0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2018.01.010","article-title":"Impact of CD14(++)CD16(+) monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients","volume":"269","author":"Yamamoto","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2011.07.067","article-title":"Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"109","author":"Hoebers","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0395","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.110.985911","article-title":"Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment&#x2013; Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention","volume":"124","author":"Timmer","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0400","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ehjcvp\/pvz028","article-title":"The management of stress hyperglycaemia in patients experiencing acute coronary syndrome: a topic worth revisiting","volume":"6","author":"Barton","year":"2020","journal-title":"Eur heart j Cardiovascular pharmacotherapy"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0405","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.107.740498","article-title":"Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk","volume":"117","author":"Kosiborod","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0410","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2015-2660","article-title":"Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio","volume":"100","author":"Roberts","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0415","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.ijcard.2012.06.054","article-title":"Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial","volume":"167","author":"Planer","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0420","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12872-016-0441-x","article-title":"Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"17","author":"Hao","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0425","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.amjcard.2009.04.055","article-title":"Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus","volume":"104","author":"Ishihara","year":"2009","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-022-01479-8","article-title":"Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110644_b0435","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-022-01893-0","article-title":"Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction","author":"Schmitz","year":"2022","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12933-021-01395-3","article-title":"Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients","volume":"20","author":"Sia","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0445","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-017-0642-3","article-title":"Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data","volume":"16","author":"Lee","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management","volume":"7","author":"Amiel","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"10.1016\/j.diabres.2023.110644_b0455","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehi230","article-title":"Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events","volume":"26","author":"Svensson","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2005.03.052","article-title":"U-shaped relationship of blood glucose with adverse outcomes among patients With ST-Segment Elevation Myocardial Infarction","volume":"46","author":"Pinto","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-020-01204-3","article-title":"Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention : structured intervention for community hypoglycemia","volume":"20","author":"Pearson","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0470","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1615692","article-title":"Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes","volume":"377","author":"Marso","year":"2017","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.diabres.2023.110644_b0475","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0480","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00592-015-0803-3","article-title":"Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis","volume":"53","author":"Yeh","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2023.110644_b0485","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ : British Medical Journal"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0490","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/CRD.0000000000000276","article-title":"Severe Hypoglycemia and Risk of Subsequent cardiovascular events: systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Malik","year":"2020","journal-title":"Cardiol Rev"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0495","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.numecd.2013.05.003","article-title":"Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls","volume":"24","author":"Ceriello","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0500","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/db08-1153","article-title":"Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control","volume":"58","author":"Adler","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0505","doi-asserted-by":"crossref","first-page":"R215","DOI":"10.1152\/ajpregu.00531.2011","article-title":"The physiology and pathophysiology of the neural control of the counterregulatory response","volume":"302","author":"Beall","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"10.1016\/j.diabres.2023.110644_b0510","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diacare.21.9.1505","article-title":"Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects","volume":"21","author":"Fritsche","year":"1998","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2023.110644_b0515","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/hrt.2008.152835","article-title":"Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial","volume":"95","author":"Mellbin","year":"2009","journal-title":"Heart"},{"issue":"24","key":"10.1016\/j.diabres.2023.110644_b0520","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1161\/CIRCULATIONAHA.108.837765","article-title":"Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction","volume":"120","author":"Goyal","year":"2009","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.diabres.2023.110644_b0525","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction","volume":"301","author":"Kosiborod","year":"2009","journal-title":"J Am Med Assoc"},{"issue":"13","key":"10.1016\/j.diabres.2023.110644_b0530","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"The NICE-SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0535","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"The NICE-SUGAR Study Investigators. Hypoglycemia and Risk of Death in Critically Ill Patients","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0540","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMe1208208","article-title":"Understanding Low Sugar from NICE-SUGAR","volume":"367","author":"Hirsch","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2023.110644_b0545","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2017.08.012","article-title":"The risks of nocturnal hypoglycaemia in insulin-treated diabetes","volume":"133","author":"Graveling","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0550","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.diabres.2023.110644_b0555","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward defining the threshold between low and high glucose variability in diabetes","volume":"40","author":"Monnier","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0560","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/dia.2011.0049","article-title":"The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes","volume":"13","author":"Monnier","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0565","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","article-title":"Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)","volume":"61","author":"Zinman","year":"2018","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2023.110644_b0570","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jdiacomp.2015.04.008","article-title":"Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes","volume":"29","author":"Yang","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0575","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/eurheartj\/ehs384","article-title":"The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial","volume":"34","author":"Mellbin","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0580","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/dc10-1684","article-title":"A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction: a reanalysis of the HEART2D study","volume":"34","author":"Siegelaar","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110644_b0585","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.03.365","article-title":"Impact of glycemic variability in patients with ST-elevated myocardial infarction","volume":"187","author":"Tokue","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2023.110644_b0590","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2017.01.022","article-title":"Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up","volume":"466","author":"Xia","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0595","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1253\/circj.CJ-13-0723","article-title":"Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction","volume":"78","author":"Teraguchi","year":"2014","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0600","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1253\/circj.CJ-14-1226","article-title":"Glycemic Variability Determined by Continuous Glucose Monitoring System Predicts Left Ventricular Remodeling in Patients With a First ST-Segment Elevation Myocardial Infarction","volume":"79","author":"Gohbara","year":"2015","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0605","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12933-016-0395-4","article-title":"Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography","volume":"15","author":"Kuroda","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110644_b0610","article-title":"Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin","volume":"1","author":"Malanda","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diabres.2023.110644_b0615","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1136\/bmj.e486","article-title":"Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes","volume":"344","author":"Farmer","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0620","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110644_b0625","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac034","article-title":"Complications of diabetes and metrics of glycaemic management derived from continuous glucose monitoring","author":"Yapanis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0630","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients With Type 2 Diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2023.110644_b0635","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in range is associated with carotid intima-media thickness in type 2 diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.diabres.2023.110644_b0640","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1007\/s00125-021-05474-8","article-title":"Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: the Maastricht Study","volume":"64","author":"Foreman","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0645","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/1932296820982584","article-title":"Mitigation of rebound hyperglycemia with real-time continuous glucose monitoring data and predictive alerts","volume":"16","author":"Acciaroli","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.diabres.2023.110644_b0650","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: the DIAMOND Randomized Clinical Trial","volume":"317","author":"Beck","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.diabres.2023.110644_b0655","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/dme.12713","article-title":"Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)","volume":"32","author":"New","year":"2015","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.diabres.2023.110644_b0660","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.110644_b0665","unstructured":"National Institute for Health and Care Excellence (2022). Type 2 diabetes in adults: management (NICE guideline NG28). https:\/\/www.nice.org.uk\/guidance\/ng28\/resources\/type-2-diabetes-in-adults-management-pdf-1837338615493 (accessed 1st June 2022."},{"issue":"22","key":"10.1016\/j.diabres.2023.110644_b0670","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: a Randomized Clinical Trial","volume":"325","author":"Martens","year":"2021","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0675","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diabres.2008.06.015","article-title":"Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes","volume":"82","author":"Yoo","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0680","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2008.01.006","article-title":"Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial","volume":"80","author":"Allen","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2023.110644_b0685","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc11-1438","article-title":"Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes","volume":"35","author":"Vigersky","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2023.110644_b0690","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/193229681100500320","article-title":"The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus","volume":"5","author":"Ehrhardt","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2023.110644_b0695","first-page":"dc221219","article-title":"Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial","author":"Ajjan","year":"2022","journal-title":"Diabetes Care"},{"key":"#cr-split#-10.1016\/j.diabres.2023.110644_b0700.1","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - Identifier NCT05431296, Glucose Control Using Continuous Glucose Monitoring in People With Type 2 Diabetes Who Have Had Acute Myocardial Infarct (GLAM)"},{"key":"#cr-split#-10.1016\/j.diabres.2023.110644_b0700.2","unstructured":"2022 24 June [cited 21 Aug 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05431296?term=GLAM&draw=2&rank=3."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:26:26Z","timestamp":1759173986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723004047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":141,"alternative-id":["S0168822723004047"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110644","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycaemic control in people with diabetes following acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110644"}}